Latest News
Pharmasset: hepatitis C drug trial will continue
San Francisco Chronicle | 9 hours 27 minutes ago
You must be signed in to add a comment. Sign In | Register... (more)
Spray can prevent premature ejaculation: study
Yahoo! | 9 hours 31 minutes ago
WASHINGTON (Reuters) ? A spray that numbs the penis can help prevent premature ejaculation, doctors reported on Thursday, and drug maker Sciele Pharma Inc, a division of Japan's Shionogi, plans to file for U.S. approval next year.... (more)
Jury: Pfizer must pay $6.3M damages in HRT case
Philadelphia Inquirer, The | 9 hours 32 minutes ago
Bloomberg News reported that a Philadelphia jury has awarded an Illinois woman at least $6.3 million in damages after finding that two Pfizer Inc. hormone- replacement therapy drugs, Prempro and Provera, caused her breast cancer and led to her having a double mastectomy in 2002.... (more)
Pharmasset says Roche will continue enrolling subjects in RG7128 trial after committee review
Star Tribune (Minneapolis-St. Paul, Minn.) | 9 hours 37 minutes ago
NEW YORK - Pharmasset Inc. said Monday that it will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.... (more)
Britain's GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer
Star Tribune (Minneapolis-St. Paul, Minn.) | 9 hours 39 minutes ago
TRENTON, N.J. - British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S.... (more)
GlaxoSmithKline pulls application for new drug use
San Francisco Chronicle | 10 hours 9 minutes ago
You must be signed in to add a comment. Sign In | Register... (more)
Wire Business News
Sacramento Bee (Calif.), The | 10 hours 10 minutes ago
TRENTON, N.J. -- British drugmaker GlaxoSmithKline PLC says it's withdrawing its application for U.S. approval of a drug to prevent prostate cancer.... (more)
Neurobiological declares special payout
American City Business Journals | 10 hours 12 minutes ago
The other shoe has dropped as Neurobiological Technologies on Monday declared a special dividend following shareholder approval in October to dissolve the company.... (more)
Seattle Genetics to get $12M from Agensys
American City Business Journals | 10 hours 13 minutes ago
Seattle Genetics Inc. said it will receive $12 million from Agensys Inc.... (more)
Monday's biggest gaining and declining stocks
Investor's Business Daily | 10 hours 13 minutes ago
NEW YORK (MarketWatch) -- Shares of the following companies were making noteworthy moves in the U.S. stock market on Monday:... (more)
Rigel shares rise on RBC analyst upgrade
Miami Herald, The | 10 hours 13 minutes ago
NEW YORK -- Rigel Pharmaceuticals Inc. rose after an RBC Capital Markets analyst recommended buying shares of the drug developer based on his expectations the company will announce news of a partnership for a key drug candidate.... (more)
Earnings Preview: Medtronic
ABC News | 10 hours 18 minutes ago
Analysts monitoring heart implant sales as Medtronic reports second-quarter earns... (more)
390 Stories | 
RSS Feed
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Diabetics show alarming increase in morbid obesity
Science Blog
New discovery about the formation of new brain cells
Science Blog
Why not mashed paper towels on the Thanksgiving menu?
Science Blog
Fat around the middle increases the risk of dementia
Science Blog
Job Listingsview more
- Health Policy Analyst and Programmer
Genentech - Advertising Associate Attorney
Manatt, Phelps & Phillips LLP - Sr. Paralegal (Pharmaceutical Contracts/Transactions)
Endo Pharmaceuticals
Companies in the news
- Antigenics Incorporated
- Bayer
- BioCryst Pharmaceuticals Inc.
- Covidien PLC
- Dendreon Corp
- EMPI
- Eli Lilly and Co.
- GlaxoSmithKline plc